Cardiac metastases are an infrequent site of metastasis in neuroendocrine tumors, and the treatment implications in the era of peptide receptor radionuclide therapy (PRRT) are unclear. Potential safety concerns exist regarding cardiac integrity and function in response to PRRT. We describe our institutional experience with 4 patients with well-differentiated, midgut neuroendocrine tumors with cardiac involvement detected on Ga-DOTATATE PET/CT scans who were treated with PRRT.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/RLU.0000000000003283 | DOI Listing |
Publication Analysis
Top Keywords
peptide receptor
8
receptor radionuclide
8
radionuclide therapy
8
cardiac metastases
8
neuroendocrine tumors
8
therapy patients
4
patients neuroendocrine
4
neuroendocrine tumor
4
cardiac
4
tumor cardiac
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!